Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors
Clinical trial NCT00942799 · COMPLETED
Trial details
- NCT number
- NCT00942799
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2013-01-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.